Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
Stopped early · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying temozolomide to see how well it works in treating patients with mycosis fungoides or Sezary syndrome that has not responded to previous treatment.
Key facts
- Study ID
- NCT00004106
- Run by
- Northwestern University
- People needed
- 29
- Starts
- 1998-05-01
- Expected to finish
- 2006-04-01
- Last updated by the study team
- 2012-06-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Yale Comprehensive Cancer Center at Yale University School of Medicine — New Haven, Connecticut, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.